Vodobatinib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Vodobatinib, covering 2024-07-31 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Expanded Access to Vodobatinib for Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Not Responded to Previous Treatments